1. Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer. Issue 9 (28th December 2015) Authors: Nabholtz, J.M.; Chalabi, N.; Radosevic‐Robin, N.; Dauplat, M.M.; Mouret‐Reynier, M.A.; Van Praagh, I.; Servent, V.; Jacquin, JP; Benmammar, K.E.; Kullab, S.; Bahadoor, M.R.K.; Kwiatkowski, F.; Cayre, A.; Abrial, C.; Durando, X.; Bignon, Y.J.; Chollet, P.; Penault‐Llorca, F. Journal: International journal of cancer Issue: Volume 138:Issue 9(2016:May 01) Page Start: 2274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗